Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients.

PubWeight™: 4.86‹?› | Rank: Top 1%

🔗 View Article (PMC 4403874)

Published in Arch Surg on April 01, 2003

Authors

Carlos Fernández-del Castillo1, Javier Targarona, Sarah P Thayer, David W Rattner, William R Brugge, Andrew L Warshaw

Author Affiliations

1: Department of Surgery and Gastroenterology, Massachusetts General Hospital ACC/336, 15 Parkman Street, Boston, MA 02114, USA. cfernandez@partners.org

Associated clinical trials:

Management of Incidentally Discovered Pancreatic Cysts | NCT00550108

Articles citing this

(truncated to the top 100)

Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg (2004) 5.09

Prevalence of unsuspected pancreatic cysts on MDCT. AJR Am J Roentgenol (2008) 4.70

Cystic pancreatic neoplasms: observe or operate. Ann Surg (2004) 3.68

Incidental pancreatic cystic lesions: is there a relationship with the development of pancreatic adenocarcinoma and all-cause mortality? Radiology (2014) 3.39

A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients. Ann Surg (2006) 3.34

Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology (2007) 2.96

Serous cystadenoma of the pancreas: tumor growth rates and recommendations for treatment. Ann Surg (2005) 2.27

Incidental pancreatic cysts: do we really know what we are watching? Pancreatology (2010) 2.22

Serous cyst adenoma of the pancreas: appraisal of active surgical strategy before it causes problems. Surg Endosc (2011) 2.19

MicroRNA miR-155 is a biomarker of early pancreatic neoplasia. Cancer Biol Ther (2009) 2.01

Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. Clin Gastroenterol Hepatol (2009) 1.90

Precursors to pancreatic cancer. Gastroenterol Clin North Am (2007) 1.75

Current trends in pancreatic cystic neoplasms. Arch Surg (2009) 1.68

Middle pancreatectomy: indications, short- and long-term operative outcomes. Ann Surg (2007) 1.46

Evolving patterns in the detection and outcomes of pancreatic neuroendocrine neoplasms: the Massachusetts General Hospital experience from 1977 to 2005. Arch Surg (2007) 1.45

Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas. Am J Pathol (2004) 1.40

Cystic precursors to invasive pancreatic cancer. Nat Rev Gastroenterol Hepatol (2011) 1.39

Periampullary and pancreatic incidentaloma: a single institution's experience with an increasingly common diagnosis. Ann Surg (2006) 1.36

Elevated microRNA miR-21 levels in pancreatic cyst fluid are predictive of mucinous precursor lesions of ductal adenocarcinoma. Pancreatology (2011) 1.22

Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas. Ann Surg (2012) 1.22

Global genomic analysis of intraductal papillary mucinous neoplasms of the pancreas reveals significant molecular differences compared to ductal adenocarcinoma. Ann Surg (2009) 1.17

Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreas. Ann Surg Oncol (2010) 1.13

Cyst fluid interleukin-1beta (IL1beta) levels predict the risk of carcinoma in intraductal papillary mucinous neoplasms of the pancreas. Clin Cancer Res (2011) 1.11

Outcomes of cystic lesions in the pancreas after extended follow-up. Dig Dis Sci (2007) 1.09

Management of mucinous cystic neoplasms of the pancreas. World J Gastroenterol (2010) 1.09

Pancreatic cyst prevalence and the risk of mucin-producing adenocarcinoma in US adults. Am J Gastroenterol (2013) 1.08

Serum fatty acid synthase as a marker of pancreatic neoplasia. Cancer Epidemiol Biomarkers Prev (2009) 1.08

A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients. Ann Surg (2007) 1.06

Pancreatic intraductal papillary-mucinous neoplasms: a new and evolving entity. Virchows Arch (2007) 1.06

The clinical relevance of the increasing incidence of intraductal papillary mucinous neoplasm. Clin Gastroenterol Hepatol (2011) 1.06

Cytology adds value to imaging studies for risk assessment of malignancy in pancreatic mucinous cysts. Ann Surg (2011) 1.05

Differences between main-duct and branch-duct intraductal papillary mucinous neoplasms of the pancreas. World J Gastrointest Surg (2010) 1.04

Accuracy of CT in predicting malignant potential of cystic pancreatic neoplasms. HPB (Oxford) (2008) 1.03

Cystic tumors of the pancreas. Cancer Imaging (2006) 1.01

Loss of expression of the SWI/SNF chromatin remodeling subunit BRG1/SMARCA4 is frequently observed in intraductal papillary mucinous neoplasms of the pancreas. Hum Pathol (2011) 0.99

Epidemiology, diagnosis, and management of cystic lesions of the pancreas. Gastroenterol Res Pract (2011) 0.98

Three cases of pancreatic serous cystadenoma and endocrine tumour. J Clin Pathol (2006) 0.98

Extent of surgical resections for intraductal papillary mucinous neoplasms. World J Gastrointest Surg (2010) 0.97

Comparison of resected and non-resected intraductal papillary mucinous neoplasms of the pancreas. World J Surg (2005) 0.96

Intraductal papillary mucinous neoplasms of the pancreas: radiological predictors of malignant transformation and the introduction of bile duct dilation to current guidelines. Br J Radiol (2016) 0.96

Association of Preoperative Risk Factors With Malignancy in Pancreatic Mucinous Cystic Neoplasms: A Multicenter Study. JAMA Surg (2016) 0.95

Multidisciplinary management strategy for incidental cystic lesions of the pancreas. J Am Coll Surg (2010) 0.95

Pancreatic cystic neoplasms: predictors of malignant behavior and management. Saudi J Gastroenterol (2013) 0.94

Cystic pancreatic neuroendocrine neoplasms with uncertain malignant potential: report of two cases. Surg Today (2009) 0.93

Intraductal papillary mucinous neoplasms and other pancreatic cystic lesions. World J Gastroenterol (2008) 0.93

Intraductal papillary mucinous neoplasia (IPMN) of the pancreas: its diagnosis, treatment, and prognosis. Dtsch Arztebl Int (2011) 0.92

Incidental pancreatic cystic lesions. World J Surg (2008) 0.91

Carcinogenesis of pancreatic adenocarcinoma: precursor lesions. Int J Mol Sci (2013) 0.91

Cytological analysis of small branch-duct intraductal papillary mucinous neoplasms provides a more accurate risk assessment of malignancy than symptoms. Cytojournal (2011) 0.89

Intraductal papillary mucinous neoplasms of the pancreas--a surgical disease. Nat Rev Gastroenterol Hepatol (2012) 0.89

Management of mucin-producing cystic neoplasms of the pancreas. Oncologist (2009) 0.89

Targeted screening of individuals at high risk for pancreatic cancer: results of a simulation model. Radiology (2014) 0.88

Simultaneous intraductal papillary neoplasms of the bile duct and pancreas treated with chemoradiotherapy. World J Gastrointest Oncol (2012) 0.88

Cyst fluid biomarkers for intraductal papillary mucinous neoplasms of the pancreas: a critical review from the international expert meeting on pancreatic branch-duct-intraductal papillary mucinous neoplasms. J Am Coll Surg (2014) 0.88

Consensus guidelines in the management of branch duct intraductal papillary mucinous neoplasm: a cost-effectiveness analysis. Dig Dis Sci (2009) 0.87

Update on pancreatic cyst fluid analysis. Ann Gastroenterol (2013) 0.87

Diagnostic evaluation of cystic pancreatic lesions. HPB (Oxford) (2008) 0.86

Intraductal papillary mucinous neoplasm and the pancreatic incidentaloma. World J Gastrointest Surg (2010) 0.85

Implications of imaging criteria for the management and treatment of intraductal papillary mucinous neoplasms - benign versus malignant findings. Eur Radiol (2014) 0.84

Left-sided portal hypertension caused by serous cystadenoma of the pancreas: report of a case. Surg Today (2008) 0.84

Which is the best current guideline for the diagnosis and management of cystic pancreatic neoplasms? An appraisal using evidence-based practice methods. Eur Radiol (2016) 0.84

Survival in cystic neoplasms of the pancreas. Can J Gastroenterol (2009) 0.83

Circulating Epithelial Cells in Patients with Pancreatic Lesions: Clinical and Pathologic Findings. J Am Coll Surg (2015) 0.83

Prevalence of incidental pancreatic cysts on 3 tesla magnetic resonance. PLoS One (2015) 0.82

Diagnosis and management of cystic lesions of the pancreas. Diagn Ther Endosc (2011) 0.82

Pancreatic cystic lesions: How endoscopic ultrasound morphology and endoscopic ultrasound fine needle aspiration help unlock the diagnostic puzzle. World J Gastrointest Endosc (2012) 0.82

Differentiation of pancreatic ductal adenocarcinoma from chronic pancreatitis by PAM4 immunohistochemistry. Arch Pathol Lab Med (2014) 0.81

Distal pancreatectomy: what is the standard for laparoscopic surgery? HPB (Oxford) (2009) 0.80

Imaging features of intraductal papillary mucinous neoplasms of the pancreas in multi-detector row computed tomography. World J Gastroenterol (2009) 0.79

Management of Incidental Pancreatic Cystic Lesions. Viszeralmedizin (2015) 0.79

Mucinous cystic neoplasm of the pancreas in a male patient. Rare Tumors (2011) 0.79

Incidental pancreatic cystic neoplasms in an asymptomatic healthy population of 21,745 individuals: Large-scale, single-center cohort study. Medicine (Baltimore) (2016) 0.79

Fate of small pancreatic cysts (<3 cm) after long-term follow-up: analysis of significant radiologic characteristics and proposal of follow-up strategies. Eur Radiol (2016) 0.78

microRNA biomarkers in cystic diseases. BMB Rep (2013) 0.78

Comparison of efficacy of enucleation and pancreaticoduodenectomy for small (<3 cm) branch duct type intraductal papillary mucinous neoplasm located at the head of pancreas and the uncinate process. Yonsei Med J (2012) 0.78

Novel xenograft and cell line derived from an invasive intraductal papillary mucinous neoplasm of the pancreas give new insights into molecular mechanisms. Pancreas (2010) 0.78

Laparoscopic central pancreatectomy for benign or low-grade malignant lesions in the pancreatic neck and proximal body. Surg Endosc (2014) 0.78

Improving patient notification of solid abdominal viscera incidental findings with a standardized protocol. J Trauma Manag Outcomes (2015) 0.77

Screening for pancreatic cancer: what can cyst fluid analysis tell us? F1000 Med Rep (2011) 0.77

IPMN: surgical treatment. Langenbecks Arch Surg (2013) 0.77

Extent of Surgery and Implications of Transection Margin Status after Resection of IPMNs. Gastroenterol Res Pract (2014) 0.77

Endoscopic ultrasound-guided fine needle aspiration in cystic pancreatic lesions. Clin Endosc (2012) 0.77

Imaging investigation of pancreatic cystic lesions and proposal for therapeutic guidelines. World J Radiol (2012) 0.77

Diagnostic accuracy of cyst fluid amphiregulin in pancreatic cysts. BMC Gastroenterol (2012) 0.77

Diagnosis and management of relapsing pancreatitis associated with cystic neoplasms of the pancreas. World J Gastroenterol (2008) 0.76

Fukuoka and AGA Criteria Have Superior Diagnostic Accuracy for Advanced Cystic Neoplasms than Sendai Criteria. Dig Dis Sci (2017) 0.76

Surgical resection and outcome of pancreatic cystic neoplasms in China: analysis of a 16-year experience from a single high-volume academic institution. World J Surg Oncol (2014) 0.75

Duodenum-preserving resection and Roux-en-Y pancreatic jejunostomy in benign pancreatic head tumors. World J Gastroenterol (2014) 0.75

Mucinous Cystic Neoplasms of Pancreas. Gastroenterology Res (2014) 0.75

Long-term outcome of cystic lesions in the pancreas: a retrospective cohort study. Gut Liver (2012) 0.75

A MicroRNA Panel in Pancreatic Cyst Fluid for the Risk Stratification of Pancreatic Cysts in a Prospective Cohort. Mol Ther Nucleic Acids (2016) 0.75

Pancreaticoduodenectomy for suspected periampullary cancers: the mimes of malignancy. HPB (Oxford) (2009) 0.75

Differentiation of mucinous cystic neoplasm and cystic changes associated with pancreatic adenocarcinoma. BMJ Case Rep (2013) 0.75

The changing spectrum of surgically treated cystic neoplasms of the pancreas. HPB Surg (2015) 0.75

Molecular pathology of intraductal papillary mucinous neoplasms of the pancreas. World J Gastroenterol (2014) 0.75

Cystic Lesions of the Pancreas: Observe or Operate. Indian J Surg (2015) 0.75

Pancreatic cystic lesion in an infant. J Indian Assoc Pediatr Surg (2011) 0.75

Validation of international consensus guideline 2012 for intraductal papillary mucinous neoplasm of pancreas. Ann Surg Treat Res (2016) 0.75

A selective approach to resection of cystic lesions of the pancreas: results from 539 consecutive patients. Ann Surg (2007) 0.75

Ethanol lavage of 14 mucinous cysts of the pancreas: A retrospective study in two tertiary centers. Endosc Ultrasound (2012) 0.75

Articles cited by this

Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization. Arch Surg (2001) 4.59

Cystic tumors of the pancreas. New clinical, radiologic, and pathologic observations in 67 patients. Ann Surg (1990) 3.46

Cystadenomas and cystadenocarcinomas of the pancreas: a multiinstitutional retrospective study of 398 cases. French Surgical Association. Ann Surg (1999) 3.09

The natural history of simple renal cysts. J Urol (2002) 2.40

Intraductal papillary-mucinous tumors of the pancreas: clinicopathologic features, outcome, and nomenclature. Members of the Pancreas Clinic, and Pancreatic Surgeons of Mayo Clinic. Gastroenterology (1996) 2.33

The prevalence and characterization of simple hepatic cysts by ultrasound examination. Br J Radiol (1989) 2.01

Cyst fluid analysis in the differential diagnosis of pancreatic cysts. A comparison of pseudocysts, serous cystadenomas, mucinous cystic neoplasms, and mucinous cystadenocarcinoma. Ann Surg (1993) 1.97

Cystic tumors mistaken for pancreatic pseudocysts. Ann Surg (1987) 1.97

The spectrum of serous cystadenoma of the pancreas. Clinical, pathologic, and surgical aspects. Ann Surg (1992) 1.96

Cystic tumors of the pancreas. Surg Clin North Am (1995) 1.82

Mucinous cystic neoplasm (mucinous cystadenocarcinoma of low-grade malignant potential) of the pancreas: a clinicopathologic study of 130 cases. Am J Surg Pathol (1999) 1.82

Cystic neoplasms of the pancreas. Arch Surg (1987) 1.65

Serum tumor markers and cyst fluid analysis are useful for the diagnosis of pancreatic cystic tumors. Cancer (1996) 1.56

Preoperative cyst fluid analysis is useful for the differential diagnosis of cystic lesions of the pancreas. Gastroenterology (1995) 1.51

Serous cystadenoma of the pancreas with invasive growth: benign or malignant? Am J Gastroenterol (1998) 1.49

Spectrum of cystic tumors of the pancreas. Am J Surg (1992) 1.45

Cystic neoplasms of the pancreas. Gastroenterology (1987) 1.39

Cystic pancreatic tumors: CT and sonographic assessment. AJR Am J Roentgenol (1988) 1.36

A rare case of serous cystadenocarcinoma of the pancreas. Cancer (1992) 1.35

Value of 18-fluorodeoxyglucose positron emission tomography in the management of patients with cystic tumors of the pancreas. Ann Surg (2001) 1.25

Endoscopic ultrasonography diagnosis of pancreatic cystic disease. Endoscopy (1998) 1.13

The role of endoscopic ultrasound in pancreatic disorders. Int J Pancreatol (1996) 0.93

Articles by these authors

Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature (2003) 10.33

Consensus statement on the pathology of IgG4-related disease. Mod Pathol (2012) 9.01

Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology (2004) 6.75

Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg (2004) 5.09

Autoimmune pancreatitis. N Engl J Med (2006) 5.00

Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum (2012) 4.27

Cystic neoplasms of the pancreas. N Engl J Med (2004) 3.89

Pancreatic ductal adenocarcinoma: long-term survival does not equal cure. Surgery (2012) 3.87

Hepatic portal venous gas: the ABCs of management. Arch Surg (2009) 3.76

In vivo lineage tracing defines the role of acinar-to-ductal transdifferentiation in inflammatory ductal metaplasia. Gastroenterology (2007) 3.41

Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma. J Clin Oncol (2006) 3.37

Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study. Gastrointest Endosc (2009) 3.32

Transcolonic endoscopic cholecystectomy: a NOTES survival study in a porcine model (with video). Gastrointest Endosc (2006) 3.32

Sigmoidectomy syndrome? Patients' perspectives on the functional outcomes following surgery for diverticulitis. Dis Colon Rectum (2012) 3.28

Isolation and characterization of centroacinar/terminal ductal progenitor cells in adult mouse pancreas. Proc Natl Acad Sci U S A (2009) 3.25

A novel somatic mouse model to survey tumorigenic potential applied to the Hedgehog pathway. Cancer Res (2006) 3.06

Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology (2007) 2.96

Comparison of a lymph node ratio-based staging system with the 7th AJCC system for gastric cancer: analysis of 18,043 patients from the SEER database. Ann Surg (2012) 2.85

Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer. Ann Surg (2015) 2.79

Paraesophageal hernias: operation or observation? Ann Surg (2002) 2.71

The impact of the 80-hour resident workweek on surgical residents and attending surgeons. Ann Surg (2006) 2.59

Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut (2012) 2.52

EUS-guided FNA for the diagnosis of GI stromal cell tumors: sensitivity and cytologic yield. Gastrointest Endosc (2009) 2.45

Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. Ann Surg (2008) 2.45

A randomized trial comparing uncovered and partially covered self-expandable metal stents in the palliation of distal malignant biliary obstruction. Gastrointest Endosc (2010) 2.38

Pancreatic cysts 3 cm or smaller: how aggressive should treatment be? Radiology (2006) 2.35

Autoimmune pancreatitis: imaging features. Radiology (2004) 2.34

Serous cystadenoma of the pancreas: tumor growth rates and recommendations for treatment. Ann Surg (2005) 2.27

Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection? Ann Surg (2013) 2.26

American Surgical Association Blue Ribbon Committee Report on Surgical Education: 2004. Ann Surg (2005) 2.25

Implications and cost of pancreatic leak following distal pancreatic resection. Arch Surg (2006) 2.25

Incidental pancreatic cysts: do we really know what we are watching? Pancreatology (2010) 2.22

PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-κB-cytokine network. Cancer Discov (2011) 2.14

Identification of surgical complications and deaths: an assessment of the traditional surgical morbidity and mortality conference compared with the American College of Surgeons-National Surgical Quality Improvement Program. J Am Coll Surg (2006) 2.07

EUS staging of upper GI malignancies: results of a prospective randomized trial. Gastrointest Endosc (2006) 2.07

Is laparoscopic inguinal hernia repair an operation of the past? J Am Coll Surg (2005) 2.05

Cystic pancreatic lesions: a simple imaging-based classification system for guiding management. Radiographics (2005) 2.03

Plectin-1 as a novel biomarker for pancreatic cancer. Clin Cancer Res (2010) 2.03

NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and laparoscopic assistance. Surg Endosc (2010) 2.00

Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw (2012) 1.97

Residency training in surgery in the 21st century: a new paradigm. Surgery (2004) 1.94

Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes. Gut (2011) 1.94

EUS-guided celiac plexus neurolysis for pain due to chronic pancreatitis or pancreatic cancer pain: a meta-analysis and systematic review. Dig Dis Sci (2009) 1.91

Long-term follow-up of pancreatic cysts that resolve radiologically after EUS-guided ethanol ablation. Gastrointest Endosc (2010) 1.91

Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. Clin Gastroenterol Hepatol (2009) 1.90

New metastatic lymph node ratio system reduces stage migration in patients undergoing D1 lymphadenectomy for gastric adenocarcinoma. Ann Surg Oncol (2010) 1.80

Pancreatic duct glands are distinct ductal compartments that react to chronic injury and mediate Shh-induced metaplasia. Gastroenterology (2009) 1.78

Implications of incidentally discovered, nonfunctioning pancreatic endocrine tumors: short-term and long-term patient outcomes. Arch Surg (2011) 1.78

FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experience. Oncologist (2013) 1.76

Esophageal injury and temperature monitoring during atrial fibrillation ablation. Circ Arrhythm Electrophysiol (2008) 1.75

Epidermal growth factor receptor kinase domain mutations in esophageal and pancreatic adenocarcinomas. Clin Cancer Res (2006) 1.75

EUS-guided photodynamic therapy with verteporfin for ablation of normal pancreatic tissue: a pilot study in a porcine model (with video). Gastrointest Endosc (2008) 1.73

Implications and management of pancreatic fistulas following pancreaticoduodenectomy: the Massachusetts General Hospital experience. Arch Surg (2008) 1.72

Cyst fluid carcinoembryonic antigen is an accurate diagnostic marker of pancreatic mucinous cysts. Pancreas (2011) 1.71

EUS-guided injection of paclitaxel (OncoGel) provides therapeutic drug concentrations in the porcine pancreas (with video). Gastrointest Endosc (2006) 1.69

Debridement and closed packing for sterile or infected necrotizing pancreatitis: insights into indications and outcomes in 167 patients. Ann Surg (2008) 1.69

851 resected cystic tumors of the pancreas: a 33-year experience at the Massachusetts General Hospital. Surgery (2012) 1.68

Current trends in pancreatic cystic neoplasms. Arch Surg (2009) 1.68

Diagnosis of pancreatic neoplasia with EUS and FNA: a report of accuracy. Gastrointest Endosc (2010) 1.68

Neutrophil metabolic activity but not neutrophil sequestration reflects the development of pancreatitis-associated lung injury. Crit Care Med (2002) 1.67

Autoimmune pancreatitis: a systemic immune complex mediated disease. Am J Surg Pathol (2006) 1.62

Concentration-dependent ablation of pancreatic tissue by EUS-guided ethanol injection. Gastrointest Endosc (2007) 1.61

Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series. Ann Surg (2013) 1.58

Gastrointestinal complications in patients undergoing heart operation: an analysis of 8709 consecutive cardiac surgical patients. Ann Surg (2005) 1.57

The inflammatory pancreatic head mass: significant differences in the anatomic pathology of German and American patients with chronic pancreatitis determine very different surgical strategies. Ann Surg (2009) 1.56

Ethanol lavage of pancreatic cystic lesions: initial pilot study. Gastrointest Endosc (2005) 1.55

Communication practices on 4 Harvard surgical services: a surgical safety collaborative. Ann Surg (2009) 1.53

The esophageal effects of cryoenergy during cryoablation for atrial fibrillation. Heart Rhythm (2009) 1.52

Endoscopic mucosal resection using a cap-fitted endoscope improves tissue resection and pathology interpretation: an animal study. Gastric Cancer (2006) 1.52

Pancreatic adenocarcinoma. J Natl Compr Canc Netw (2010) 1.52

Role of computed tomography perfusion in the evaluation of pancreatic necrosis and pancreatitis after endoscopic ultrasound-guided ablation of the pancreas in a porcine model. Pancreas (2009) 1.50

Social media in surgical education and practice. Surgery (2011) 1.50

Ethical misconduct in publishing: the editors' perspective. World J Surg (2006) 1.50

Interobserver agreement among endosonographers for the diagnosis of neoplastic versus non-neoplastic pancreatic cystic lesions. Gastrointest Endosc (2003) 1.49

A policy-based intervention for the reduction of communication breakdowns in inpatient surgical care: results from a Harvard surgical safety collaborative. Ann Surg (2011) 1.49

NOTES: Where have we been and where are we going? Surg Endosc (2008) 1.48

Middle pancreatectomy: indications, short- and long-term operative outcomes. Ann Surg (2007) 1.46